These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1813991)

  • 1. Mechanisms of granulomatous lung disease from inhaled beryllium: the role of antigenicity in granuloma formation.
    Haley PJ
    Toxicol Pathol; 1991; 19(4 Pt 1):514-25. PubMed ID: 1813991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A/J and C3H/HeJ mice.
    Nikula KJ; Swafford DS; Hoover MD; Tohulka MD; Finch GL
    Toxicol Pathol; 1997; 25(1):2-12. PubMed ID: 9061844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A canine model of beryllium-induced granulomatous lung disease.
    Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE
    Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
    Huang H; Meyer KC; Kubai L; Auerbach R
    Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models of beryllium-induced lung disease.
    Finch GL; Hoover MD; Hahn FF; Nikula KJ; Belinsky SA; Haley PJ; Griffith WC
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):973-9. PubMed ID: 8933044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease.
    Mack DG; Falta MT; McKee AS; Martin AK; Simonian PL; Crawford F; Gordon T; Mercer RR; Hoover MD; Marrack P; Kappler JW; Tuder RM; Fontenot AP
    Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8553-8. PubMed ID: 24912188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reconsideration of acute Beryllium disease.
    Cummings KJ; Stefaniak AB; Virji MA; Kreiss K
    Environ Health Perspect; 2009 Aug; 117(8):1250-6. PubMed ID: 19672405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of pulmonary granulomata induced by beryllium sulfate in the rat.
    Votto JJ; Barton RW; Gionfriddo MA; Cole SR; McCormick JR; Thrall RS
    Sarcoidosis; 1987 Mar; 4(1):71-6. PubMed ID: 2954196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic beryllium disease: a hypersensitivity disorder.
    Rossman MD
    Appl Occup Environ Hyg; 2001 May; 16(5):615-8. PubMed ID: 11370939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs.
    Barna BP; Deodhar SD; Chiang T; Gautam S; Edinger M
    Int Arch Allergy Appl Immunol; 1984; 73(1):42-8. PubMed ID: 6693180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic beryllium disease: a model of interaction between environmental exposure and genetic predisposition. Pathogenesis and clinical features (Part 2)].
    Marchand-Adam S; Guillon F; Brauner M; Valeyre D
    Rev Mal Respir; 2005 Apr; 22(2 Pt 1):271-87. PubMed ID: 16092165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive diagnosis of chronic beryllium disease in workers exposed to hazardous dust in Israel.
    Fireman E; Mazor O; Kramer M; Priel I; Lerman Y
    Occup Environ Med; 2010 Sep; 67(9):631-5. PubMed ID: 19955573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune mechanisms in beryllium lung disease.
    Deodhar SD; Barna BP
    Cleve Clin J Med; 1991; 58(2):157-60. PubMed ID: 2025920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abolition of natural tolerance and the influence of the chemical allergen beryllium on autoimmune processes.
    Alekseeva OG; Vasil'eva EV; Orlova AA
    Bull World Health Organ; 1974; 51(1):51-8. PubMed ID: 4549042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium-induced lung disease in the dog following two exposures to BeO.
    Haley PJ; Finch GL; Hoover MD; Mewhinney JA; Bice DE; Muggenburg BA
    Environ Res; 1992 Dec; 59(2):400-15. PubMed ID: 1464291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology of chronic beryllium disease.
    Samuel G; Maier LA
    Curr Opin Allergy Clin Immunol; 2008 Apr; 8(2):126-34. PubMed ID: 18317020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic beryllium disease: a model for pulmonary sarcoidosis?
    Richeldi L
    Acta Biomed; 2005; 76 Suppl 2():11-4. PubMed ID: 16350545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.